Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.03 | -$0.03 | -$0.03 |
Sinovac Biotech Ltd. last posted its earnings results on Monday, January 30th, 2023. The company reported $-0.03 earnings per share for the quarter, missing analysts' consensus estimates of $-0.02 by $0.01. The company had revenue of 307.87 M for the quarter and had revenue of 448.27 M for the year. Sinovac Biotech Ltd. has generated $-1 earnings per share over the last year ($-1.06 diluted earnings per share) and currently has a price-to-earnings ratio of -6.45. Sinovac Biotech Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
12/29/2023 | Q1 2024 | -$1.17 | $307.87 M | $307.87 M | ||
08/15/2023 | Q3 2023 | $0.17 | $140.40 M | |||
12/29/2022 | Q1 2023 | -$3.73 | $280.47 M | |||
06/28/2022 | Q3 2022 | $4.87 | $1.21 B | |||
12/30/2021 | Q1 2022 | $33.82 | $8.39 B | |||
06/28/2021 | Q3 2021 | $51.45 | $10.98 B | |||
04/22/2021 | Q1 2021 | $1.09 | $327.45 M | |||
09/29/2020 | Q4 2020 | $0.10 | $115.45 M | |||
06/30/2020 | Q3 2020 | -$0.04 | $52.33 M | |||
04/30/2020 | Q2 2020 | -$0.06 | $15.39 M | |||
04/30/2020 | Q1 2020 | $0.22 | $81.11 M | |||
11/18/2019 | Q4 2019 | $0.06 | $64.34 M | |||
07/11/2019 | Q3 2019 | $0.11 | $64.05 M | |||
04/30/2019 | Q2 2019 | $0.01 | $36.55 M | |||
04/29/2019 | Q1 2019 | -$0.02 | $53.21 M | |||
11/08/2018 | Q4 2018 | $0.12 | $53.95 M | |||
06/29/2018 | Q3 2018 | $0.10 | $75.15 M | |||
05/11/2018 | Q2 2018 | $0.15 | $47.34 M | |||
05/11/2018 | Q1 2018 | $0.26 | $107.44 M | |||
06/28/2017 | Q3 2017 | $0.19 | $66.91 M |
Sinovac Biotech Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates.
The conference call for Sinovac Biotech Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Sinovac Biotech Ltd.'s latest earnings report can be read online.
Sinovac Biotech Ltd. (:SVA) has a recorded annual revenue of $448.27 M.
Sinovac Biotech Ltd. (:SVA) has a recorded net income of $448.27 M. Sinovac Biotech Ltd. has generated $-1.06 earnings per share over the last four quarters.
Sinovac Biotech Ltd. (:SVA) has a price-to-earnings ratio of -6.45 and price/earnings-to-growth ratio is -0.06.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED